DECTOVA 10 mg/1 ml, solution for infusion bottle, 20 ml
Active ingredients: Zanamivir, Zanamivir hydrate
Commercialized according to BDPMDispensing in France: Prescription only, hospital use
Solution for infusionbottle, 20 mlintraveineuse
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- DECTOVA 10 mg/1 mL, solution pour perfusion
- Pharmaceutical form
- solution pour perfusion
- Route of administration
- intraveineuse
- Presentation description
- 1 flacon(s) en verre de 20 ml
- Marketing authorisation holder
- GLAXOSMITHKLINE TRADING SERVICES (IRLANDE)
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 5 Feb 2020
- Prescription and dispensing conditions
- Prescription only, hospital use
- List I: prescription-only medicine
- Hospital use only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
64427189CIP75506390CIP133400955063902Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| ZANAMIVIRsolution | 10 mg · 1 mL de solution | FT |
| ZANAMIVIR HYDRATÉsolution | — | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.